Skycreatures opens Hong Kong office to expand global footprint

REVIEW: Heavens biological yesterday announced the formal establishment of the Hong Kong office will be the regional hubday environment to develop biological capital markets and investor relations yesterday announced the formal establishment of the Hong Kong office, will be to develop capital markets and investor relations regional hubAs an innovation in clinical stage biopharmaceutical company focused day environment biological tumor immunity innovation and differentiation of bio-medicine research and development and commercialization of its own field of immune diseases, to fill significant unmet medical needsNew Hong Kong office is located in Central, Hong Kong, will be located in the territory of bio-day Shanghai, Beijing and Rockwell team jointly explore the international market, in order to better serve patients around the world, to "continue to develop innovative biological medicine, real change in the patient mission life "day environment biological founder and honorary chairman of the board Chairman and Managing Director DrZang five, said: "We are delighted to become part of the Hong Kong Office of the biological day environment global distribution offices in Hong Kong and we look forward to by investors, and capital marketpotential partners to establish a broader, comprehensive, strong relationships, and bring together the most transformational and innovative drugs to patients worldwide"
day environment bio listed on NASDAQ in January 2020, since 2017, China's first international success in the US-listed biotechnology companySince its inception in 2016, bio-day environment has been established in more than a dozen clinical or pre-clinical stage pipeline of innovative drug research and developmentMeanwhile, bio-day environment also extends a number of globally competitive and innovative pharmaceutical products, the United States is currently in clinical trials, and a plurality of second period in China, Phase III clinical trialsBy focusing on the development of innovative biopharmaceuticals, including monoclonal antibodies, fusion protein, a bispecific antibody drugs and other new or highly differentiated against cancer and autoimmune diseases, bio-day environment, hoping to enter the fast-growing biological drug marketBy 2025, the global biopharmaceutical market value of up to US $ 4,699 million"the establishment of the Hong Kong office is an exciting day environment biological a new chapterSince its inception in 2016, the rapid growth of bio-day environment has become one of the world's most innovative biotech companiesThe companies in Hong Kong the strategy will strengthen the close ties our full potential as well as financing and capital markets, "chief financial officer and director of biological Zhu Jielun day environment representationEditor: Meng Meng Related Tags: National , day environment biological 0 0